Walgreens is spending nearly $1.4 billion to buy the remaining stake in Shields Health Solutions it doesn’t already own as it pushes into the fast-growing specialty pharmacy business.
The drugstore chain hopes to close on the remainder of the company by the end of the year. Walgreens started building a minority investment in the privately held Shields in 2019 and that stake reached about 70% last year.
